Clinical Inertia in the Treatment of Diabetes Presented by Matt Strum, Pharm D

Clinical Inertia in the Treatment of Diabetes

Presented by Matt Strum, Pharm D

Clinical inertia, in patients with type 2 diabetes, is defined as the delay in treatment initiation or intensification, despite suboptimal diabetes control. Tight glycemic control, particularly from onset and diagnosis, leads to significant reductions in microvascular and macrovascular complications.

Dr. Matt Strum, a Pharm D with NovoNordisk, will discuss ADA and AACE guidelines to review recommendations for increasing therapy and using insulin when appropriate.

This program is targeted for clinicians (NPs, PAs, and RNs) involved in ordering/prescribing for diabetics. Interested physicians are welcome to attend, as well.

Date/Time: Wednesday, May 17 6:00 PM

Location:    MetroCare Physicians Education Room

                    1661 International Drive, suite 200

                    Memphis, TN 38120

This program is a catered dinner. RSVP to me here or by phone or email by Monday, May 15

so that we may reserve your dinner.

For more information:   Donna Pendergrass  

                                       901.261.7796

                                       This email address is being protected from spambots. You need JavaScript enabled to view it.